Biomimetic peptides for the treatment of cancer

Yuichi Mine, Hafsa Munir, Yoichi Nakanishi, Daisuke Sugiyama

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Cancer remains one of the leading causes of death worldwide, indicating that current cancer therapies are ineffective. Therefore, new treatments with high specificity and low toxicity are needed. Cancerous cells can be distinguished from normal cells based on expression of key proteins, namely surface proteins, scaffold proteins and signaling molecules. Moreover, cancer cells communicate with the tumor micro-environment consisting of a heterogenous population of cells, extracellular matrix components and soluble factors such as cytokines/chemokines and growth factors. Most therapeutic interventions have been designed to specifically target these proteins of interest. Biomimetic peptides (BPs) are artificially designed peptides that imitate the action of parent proteins or peptides. BPs can be classified into at least three types based on their target molecule: BPs that target (i) cell-surface molecules, (ii) intracellular molecules, and (iii) cancer cell-tumor microenvironment interactions. In this review, we analyze/discuss the current strategies for targeting tumors using BPs.

Original languageEnglish
Pages (from-to)3565-3570
Number of pages6
JournalAnticancer research
Volume36
Issue number7
Publication statusPublished - Jan 1 2016

Fingerprint

Biomimetics
Peptides
Neoplasms
Proteins
Cellular Microenvironment
Tumor Microenvironment
Chemokines
Extracellular Matrix
Cause of Death
Intercellular Signaling Peptides and Proteins
Membrane Proteins
Cytokines
Therapeutics
Population

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Mine, Y., Munir, H., Nakanishi, Y., & Sugiyama, D. (2016). Biomimetic peptides for the treatment of cancer. Anticancer research, 36(7), 3565-3570.

Biomimetic peptides for the treatment of cancer. / Mine, Yuichi; Munir, Hafsa; Nakanishi, Yoichi; Sugiyama, Daisuke.

In: Anticancer research, Vol. 36, No. 7, 01.01.2016, p. 3565-3570.

Research output: Contribution to journalReview article

Mine, Y, Munir, H, Nakanishi, Y & Sugiyama, D 2016, 'Biomimetic peptides for the treatment of cancer', Anticancer research, vol. 36, no. 7, pp. 3565-3570.
Mine Y, Munir H, Nakanishi Y, Sugiyama D. Biomimetic peptides for the treatment of cancer. Anticancer research. 2016 Jan 1;36(7):3565-3570.
Mine, Yuichi ; Munir, Hafsa ; Nakanishi, Yoichi ; Sugiyama, Daisuke. / Biomimetic peptides for the treatment of cancer. In: Anticancer research. 2016 ; Vol. 36, No. 7. pp. 3565-3570.
@article{a9ad26f21d644225857161e78ba23bc6,
title = "Biomimetic peptides for the treatment of cancer",
abstract = "Cancer remains one of the leading causes of death worldwide, indicating that current cancer therapies are ineffective. Therefore, new treatments with high specificity and low toxicity are needed. Cancerous cells can be distinguished from normal cells based on expression of key proteins, namely surface proteins, scaffold proteins and signaling molecules. Moreover, cancer cells communicate with the tumor micro-environment consisting of a heterogenous population of cells, extracellular matrix components and soluble factors such as cytokines/chemokines and growth factors. Most therapeutic interventions have been designed to specifically target these proteins of interest. Biomimetic peptides (BPs) are artificially designed peptides that imitate the action of parent proteins or peptides. BPs can be classified into at least three types based on their target molecule: BPs that target (i) cell-surface molecules, (ii) intracellular molecules, and (iii) cancer cell-tumor microenvironment interactions. In this review, we analyze/discuss the current strategies for targeting tumors using BPs.",
author = "Yuichi Mine and Hafsa Munir and Yoichi Nakanishi and Daisuke Sugiyama",
year = "2016",
month = "1",
day = "1",
language = "English",
volume = "36",
pages = "3565--3570",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "7",

}

TY - JOUR

T1 - Biomimetic peptides for the treatment of cancer

AU - Mine, Yuichi

AU - Munir, Hafsa

AU - Nakanishi, Yoichi

AU - Sugiyama, Daisuke

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Cancer remains one of the leading causes of death worldwide, indicating that current cancer therapies are ineffective. Therefore, new treatments with high specificity and low toxicity are needed. Cancerous cells can be distinguished from normal cells based on expression of key proteins, namely surface proteins, scaffold proteins and signaling molecules. Moreover, cancer cells communicate with the tumor micro-environment consisting of a heterogenous population of cells, extracellular matrix components and soluble factors such as cytokines/chemokines and growth factors. Most therapeutic interventions have been designed to specifically target these proteins of interest. Biomimetic peptides (BPs) are artificially designed peptides that imitate the action of parent proteins or peptides. BPs can be classified into at least three types based on their target molecule: BPs that target (i) cell-surface molecules, (ii) intracellular molecules, and (iii) cancer cell-tumor microenvironment interactions. In this review, we analyze/discuss the current strategies for targeting tumors using BPs.

AB - Cancer remains one of the leading causes of death worldwide, indicating that current cancer therapies are ineffective. Therefore, new treatments with high specificity and low toxicity are needed. Cancerous cells can be distinguished from normal cells based on expression of key proteins, namely surface proteins, scaffold proteins and signaling molecules. Moreover, cancer cells communicate with the tumor micro-environment consisting of a heterogenous population of cells, extracellular matrix components and soluble factors such as cytokines/chemokines and growth factors. Most therapeutic interventions have been designed to specifically target these proteins of interest. Biomimetic peptides (BPs) are artificially designed peptides that imitate the action of parent proteins or peptides. BPs can be classified into at least three types based on their target molecule: BPs that target (i) cell-surface molecules, (ii) intracellular molecules, and (iii) cancer cell-tumor microenvironment interactions. In this review, we analyze/discuss the current strategies for targeting tumors using BPs.

UR - http://www.scopus.com/inward/record.url?scp=84992026466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992026466&partnerID=8YFLogxK

M3 - Review article

C2 - 27354624

AN - SCOPUS:84992026466

VL - 36

SP - 3565

EP - 3570

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 7

ER -